Perioperative Early Tiredness (Acute Fatigue) in Patients With Epithelial Ovarian Cancer
NCT03131102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-04-26
Summary
In surgical patients early risk prediction of postoperative complications and organ dysfunctions is still an important clinical challenge whereas appropriate risk predictors are still missing. In this regard, fatigue is a complex phenomenon, is affected by many factors and has been shown to be associated with delayed return to normal activity after surgery. The investigators hypothesize that early tiredness (acute fatigue) assessed shortly after surgery is associated to postoperative complications and organ dysfunctions and might be used for risk stratification. Therefore, in this prospective, observational study the investigators introduce and evaluate a newly developed score to assess early fatigue during the perioperative period ("Acute Fatigue Score", AFS).
The AFS and the Identity-Consequence Fatigue Scala will be used to assess early fatigue and perioperative time courses and inter-rater-variability will be evaluated. The rating of these two fatigue scores will be evaluated regarding the association with hemodynamic, immunologic, endothelial, metabolic, gastrointestinal measures as well as organ dysfunction and complications after surgery.
Furthermore, hemodynamic, immunologic, endothelial, metabolic and gastrointestinal measures are investigated with respect to the intraoperative course and postoperative organ dysfunction and complications. In a subgroup of patients, patients will undergo specialized metabolic measures to investigate mitochondrial dysfunction during the perioperative period.
Conditions
- Perioperative Early Tiredness (Acute Fatigue)
- Electrical Cardiometry
- Biosignals
- Mitochondrial Dysfunction
- Nutrition
Sponsors & Collaborators
-
Experimental & Clinical Research Center Berlin
collaborator UNKNOWN -
German Institute of Human Nutrition
collaborator OTHER -
Humboldt-Universität zu Berlin
collaborator OTHER -
Technische Universität Berlin
collaborator OTHER -
Aarne Feldheiser
lead OTHER
Principal Investigators
-
Oliver Hunsicker, MD · Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum, Charité - University Medicine Berlin
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-29
- Primary Completion
- 2018-10-09
- Completion
- 2018-10-09
Countries
- Germany
Study Locations
More Related Trials
-
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
NCT04204811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
NCT03491033 ·Status: COMPLETED
-
Role of Surgery in Advanced Ovarian Cancer
NCT03980028 ·Status: COMPLETED
-
Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients
NCT07039331 ·Status: RECRUITING ·Phase: NA
-
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
NCT06445621 ·Status: RECRUITING
-
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
NCT01492920 ·Status: WITHDRAWN ·Phase: PHASE3
-
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
NCT00006356 ·Status: TERMINATED ·Phase: PHASE3
-
Phase III Trial of Stage I Ovarian Cancer After Surgery
NCT04063527 ·Status: RECRUITING ·Phase: PHASE3
-
Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer
NCT04300699 ·Status: UNKNOWN ·Phase: NA
-
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NCT02828618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
NCT06386887 ·Status: RECRUITING ·Phase: NA
-
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NCT03418844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessing Urinary Hormones in Female Cancer Survivors
NCT03197532 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2
-
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
NCT06304922 ·Status: NOT_YET_RECRUITING
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
NCT06710548 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
NCT05371301 ·Status: UNKNOWN ·Phase: PHASE3
-
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
NCT06800105 ·Status: RECRUITING
-
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
NCT05047926 ·Status: COMPLETED ·Phase: NA
-
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
NCT06412510 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00003636 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Survivors in Ovarian Cancer
NCT03128294 ·Status: TERMINATED
-
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT01372787 ·Status: UNKNOWN
-
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
NCT01422265 ·Status: COMPLETED